A detailed history of Numerai Gp LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Numerai Gp LLC holds 1,275 shares of BIO stock, worth $438,345. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,275
Previous 1,237 3.07%
Holding current value
$438,345
Previous $428 Million 18.61%
% of portfolio
0.13%
Previous 0.18%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$268.26 - $339.48 $10,193 - $12,900
38 Added 3.07%
1,275 $348 Million
Q1 2024

May 15, 2024

BUY
$304.11 - $351.99 $130,159 - $150,651
428 Added 52.9%
1,237 $428 Million
Q4 2023

Feb 14, 2024

BUY
$269.37 - $365.04 $217,920 - $295,317
809 New
809 $261 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.47B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Numerai Gp LLC Portfolio

Follow Numerai Gp LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Numerai Gp LLC, based on Form 13F filings with the SEC.

News

Stay updated on Numerai Gp LLC with notifications on news.